Filing Details

Accession Number:
0001209191-21-043205
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-25 07:58:07
Reporting Period:
2021-06-24
Accepted Time:
2021-06-25 07:58:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1693011 Inozyme Pharma Inc. INZY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579247 Axel Bolte C/O Inozyme Pharma, Inc.
321 Summer Street Suite 400
Boston MA 02210
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-24 66,788 $0.98 257,613 No 4 M Direct
Common Stock Disposition 2021-06-24 66,788 $0.00 190,825 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-06-24 66,788 $0.00 66,788 $0.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,480 2027-06-27 No 4 M Direct
Footnotes
  1. Represents a transfer by Reporting Person to HBM Partners AG in satisfaction of Reporting Person's obligation pursuant to a prior agreement with Reporting Person's former employer.
  2. These options are fully vested.